UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Patients' and physicians' interpretation of chemotherapy‐induced peripheral neurotoxicity

Journal of the peripheral nervous system, 2019-03, Vol.24 (1), p.111-119

2019

Volltextzugriff (PDF)

Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Adult Medulloblastoma Workshop

Neuro-oncology advances, 2020-01, Vol.2 (1), p.vdaa097

2020

Volltextzugriff (PDF)

Reply to Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma

Cancer, 2019-04, Vol.125 (8), p.1385-1386

2019

Volltextzugriff (PDF)

Neurocognitive dysfunction in adult cerebellar medulloblastoma

Psycho-oncology (Chichester, England), 2019-01, Vol.28 (1), p.131-138

2019

Volltextzugriff (PDF)

Ependymomas arising outside of the central nervous system: A case series and literature review

Journal of clinical neuroscience, 2018-01, Vol.47, p.202-207

2018

Volltextzugriff (PDF)

Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial

Clinical cancer research, 2021-08, Vol.27 (16), p.4491-4499

2021

Volltextzugriff (PDF)

Pediatric versus Adult Medulloblastoma: Towards a Definition That Goes beyond Age

Cancers, 2021-12, Vol.13 (24), p.6313

2021

Volltextzugriff (PDF)

ACTR-31. PHASE 1 STUDY OF AG-881, AN INHIBITOR OF MUTANT IDH1 AND IDH2: RESULTS FROM THE RECURRENT/PROGRESSIVE GLIOMA POPULATION

Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (suppl_6), p.vi18-vi18

2018

Volltextzugriff (PDF)

C11orf95–RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma

Brain tumor pathology, 2015-04, Vol.32 (2), p.105-111

2015

Volltextzugriff (PDF)

Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study

Journal for immunotherapy of cancer, 2020-12, Vol.8 (2), p.e001532

2020

Volltextzugriff (PDF)

CATNON interim results: another triumph of upfront chemotherapy in glioma

Neuro-oncology (Charlottesville, Va.), 2017-10, Vol.19 (10), p.1287-1288

2017

Volltextzugriff (PDF)

A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma

Neuro-oncology (Charlottesville, Va.), 2020-10, Vol.22 (10), p.1505-1515

2020

Volltextzugriff (PDF)

NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients

Journal of neuro-oncology, 2018-03, Vol.137 (1), p.39-47

2018

Volltextzugriff (PDF)

Heterogeneous clinicopathological findings and patient-reported outcomes in adults with MN1 -altered CNS tumors: A case report and systematic literature review

Frontiers in oncology, 2023-01, Vol.13, p.1099618

2023

Volltextzugriff (PDF)

Treatment, prognostic factors, and outcomes in spinal cord astrocytomas

Neuro-oncology (Charlottesville, Va.), 2013-04, Vol.15 (4), p.406-412

2013

Volltextzugriff (PDF)

The Alliance AMBUSH Trial: Rationale and Design

Cancers, 2022-01, Vol.14 (2), p.414

2022

Volltextzugriff (PDF)

Recent Therapeutic Advances in Pituitary Carcinoma

Journal of Immunotherapy and Precision Oncology, 2023-05, Vol.6 (2), p.74-83

2023

Volltextzugriff (PDF)

Clinical Outcomes and Patterns of Failure in Pineoblastoma: A 30-Year, Single-Institution Retrospective Review

World neurosurgery, 2014-12, Vol.82 (6), p.1232-1241

2014

Volltextzugriff (PDF)

Neuromuscular Weakness Syndromes from Immune Checkpoint Inhibitors: A Case Series and Literature Review

Journal of Immunotherapy and Precision Oncology, 2019-08, Vol.2 (3), p.93-100

2019

Volltextzugriff (PDF)

Middle cerebral artery territory infarct due to Cryptococcus infectionstitle

Diagnostic cytopathology, 2015-08, Vol.43 (8), p.632-634

2015

Volltextzugriff (PDF)

Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post Immunotherapy

Frontiers in oncology, 2021-01, Vol.10, p.601452

2021

Volltextzugriff (PDF)

PET-Florbetapir findings in primary cerebral amyloidoma

Journal of neurology, 2015-04, Vol.262 (4), p.1052-1054

2015

Volltextzugriff (PDF)

Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas

Clinical and translational radiation oncology, 2019-02, Vol.15, p.46-52

2019

Volltextzugriff (PDF)

Results of NRG oncology/RTOG 9813: A phase III randomized study of radiation therapy (RT) and temozolomide (TMZ) versus RT and nitrosourea (NU) therapy for anaplastic astrocytoma (AA)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.2002-2002

2015

Volltextzugriff (PDF)

1 – 25 von 214

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(203)
Mit Volltextzugriff
(202)

Publikationsform

Artikel
(211)
Berichte
(3)

Sprache

Englisch
(208)
Japanisch
(13)
Spanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Patients' and physicians' interpretation of chemotherapy‐induced peripheral neurotoxicity

Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Adult Medulloblastoma Workshop

Reply to Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma

Phase 1 lead‐in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma

Neurocognitive dysfunction in adult cerebellar medulloblastoma

Ependymomas arising outside of the central nervous system: A case series and literature review

Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial

Pediatric versus Adult Medulloblastoma: Towards a Definition That Goes beyond Age

ACTR-31. PHASE 1 STUDY OF AG-881, AN INHIBITOR OF MUTANT IDH1 AND IDH2: RESULTS FROM THE RECURRENT/PROGRESSIVE GLIOMA POPULATION

C11orf95–RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma

Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study

CATNON interim results: another triumph of upfront chemotherapy in glioma

A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma

NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients

Heterogeneous clinicopathological findings and patient-reported outcomes in adults with MN1 -altered CNS tumors: A case report and systematic literature review

Treatment, prognostic factors, and outcomes in spinal cord astrocytomas

The Alliance AMBUSH Trial: Rationale and Design

Recent Therapeutic Advances in Pituitary Carcinoma

Clinical Outcomes and Patterns of Failure in Pineoblastoma: A 30-Year, Single-Institution Retrospective Review

Neuromuscular Weakness Syndromes from Immune Checkpoint Inhibitors: A Case Series and Literature Review

Middle cerebral artery territory infarct due to Cryptococcus infectionstitle

Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post Immunotherapy

PET-Florbetapir findings in primary cerebral amyloidoma

Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas

Results of NRG oncology/RTOG 9813: A phase III randomized study of radiation therapy (RT) and temozolomide (TMZ) versus RT and nitrosourea (NU) therapy for anaplastic astrocytoma (AA)

Suchergebnisse filtern